uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 16, 2019

CVS Settles Lawsuit Over Claims Its Omega-3 Supplement Improves Memory

CVS has agreed to settle charges from a class action lawsuit alleging it made false claims that its CVS brand Algal-900 DHA supplement was proven to improve memory. The product contains DHA (an omega-3 fatty acid) derived from algae, and was promoted with statements such as "clinically shown to improve memory" and "clinically shown memory improvement" on its label and packaging.

The lawsuit contended that these claims were false and misleading because "Comprehensive, high-quality clinical studies have shown that omega-3 fatty acids, including DHA, work no better than a placebo in tests of adults' cognitive performance."

As part of the settlement, consumers who purchased CVS Algal-900 DHA in the U.S. between November 15, 2008 and September 30, 2016 labeled with the claims "clinically shown to improve memory" or "clinically shown memory improvement" may be entitled to a refund. Information for consumers who wish to file a claim for a refund can find more information and instructions here. Claims must be submitted online or postmarked by December 12, 2019.

For more about the evidence for omega-3 fatty acid supplements for memory and other uses, see ConsumerLab's Fish Oil and Omega-3 Fatty Acid Supplements Review.

Also see our answer to the question: Do any supplements really help with brain function, like memory and cognition?

For more information about the class action lawsuit and refunds, see use the link below.